CHARTWELL RX FDA Approval ANDA 061996

ANDA 061996

CHARTWELL RX

FDA Drug Application

Application #061996

Application Sponsors

ANDA 061996CHARTWELL RX

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001TABLET;ORAL125MG0FULVICIN P/GGRISEOFULVIN, ULTRAMICROCRYSTALLINE
002TABLET;ORAL250MG0FULVICIN P/GGRISEOFULVIN, ULTRAMICROCRYSTALLINE
003TABLET;ORAL165MG0FULVICIN P/G 165GRISEOFULVIN, ULTRAMICROCRYSTALLINE
004TABLET;ORAL330MG0FULVICIN P/G 330GRISEOFULVIN, ULTRAMICROCRYSTALLINE

FDA Submissions

ORIG1AP1982-04-06
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2001-01-26

Submissions Property Types

SUPPL7Null0

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB

CDER Filings

CHARTWELL RX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 61996
            [companyName] => CHARTWELL RX
            [docInserts] => ["",""]
            [products] => [{"drugName":"FULVICIN P\/G","activeIngredients":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","strength":"125MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"FULVICIN P\/G","activeIngredients":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"FULVICIN P\/G 165","activeIngredients":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","strength":"165MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"FULVICIN P\/G 330","activeIngredients":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","strength":"330MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"FULVICIN P\/G","submission":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","actionType":"125MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"FULVICIN P\/G","submission":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","actionType":"250MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"FULVICIN P\/G 165","submission":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","actionType":"165MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"FULVICIN P\/G 330","submission":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","actionType":"330MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.